phenothiazine has been researched along with Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blower, PE; Durinck, S; Futreal, AP; Ikediobi, ON; Reimers, M; Stratton, MR; Weinstein, JN | 1 |
| Wondrak, GT | 1 |
2 other study(ies) available for phenothiazine and Melanoma
| Article | Year |
|---|---|
In vitro differential sensitivity of melanomas to phenothiazines is based on the presence of codon 600 BRAF mutation.
Topics: Amino Acid Substitution; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Codon; Drug Screening Assays, Antitumor; Glutamic Acid; Humans; Melanoma; Mutant Proteins; Mutation; Phenothiazines; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-raf; ras Proteins; Reproducibility of Results; Valine | 2008 |
NQO1-activated phenothiazinium redox cyclers for the targeted bioreductive induction of cancer cell apoptosis.
Topics: Apoptosis; Caspase 3; Cell Death; Cell Line, Tumor; Cell Survival; Enzyme Activation; Humans; Melanoma; Membrane Potential, Mitochondrial; NAD(P)H Dehydrogenase (Quinone); Neoplasms; Oxidation-Reduction; Oxidative Stress; Phenothiazines | 2007 |